Form 4 O'connell Daniel P

Statement of changes in beneficial ownership of securities

Published: 2018-10-22 21:23:52
Submitted: 2018-10-22
Period Ending In: 2018-10-18
doc4.html FORM 4 SUBMISSION


>

SEC FORM 4

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
O'Connell Daniel P

(Last) (First) (Middle)
C/O LOGICBIO THERAPEUTICS, INC.
610 MAIN ST., 3RD FLOOR

(Street)
CAMBRIDGE 02139

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LogicBio Therapeutics, Inc. [ LOGC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/18/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $10 10/18/2018 A 24,102 (1) 10/17/2028 Common Stock 24,102 $0.00 24,102 D
Explanation of Responses:
1. The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, October 18, 2018.
Remarks:
/s/ Matthias Jaffe, as Attorney-in-Fact 10/22/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
1
doc4.xml FORM 4 SUBMISSION
Schema Version:
X0306
Document Type:
4
Period Of Report:
2018-10-18
Not Subject To Section16:
0

Issuer

Issuer Cik
0001664106
Issuer Name
LogicBio Therapeutics, Inc.
Issuer Trading Symbol
LOGC

Reporting Owner

Reporting Owner Id

Rpt Owner Cik
0001752965
Rpt Owner Name
O'Connell Daniel P

Reporting Owner Address

Rpt Owner Street1
C/O LOGICBIO THERAPEUTICS, INC.
Rpt Owner Street2
610 MAIN ST., 3RD FLOOR
Rpt Owner City
CAMBRIDGE
Rpt Owner Zip Code
02139

Reporting Owner Relationship

Is Director
1
Is Officer
0
Is Ten Percent Owner
0
Is Other
0

Derivative Transaction

Security Title
Stock Option (right to buy)
Conversion Or Exercise Price
10.00
Transaction Date
2018-10-18

Transaction Coding

Transaction Form Type
4
Transaction Code
A
Equity Swap Involved
0

Transaction Amounts

Transaction Shares
24102
Transaction Price Per Share
0.00
Transaction Acquired Disposed Code
A
@attributes Id
F1
Expiration Date
2028-10-17

Underlying Security

Underlying Security Title
Common Stock
Underlying Security Shares
24102
Shares Owned Following Transaction
24102
Direct Or Indirect Ownership
D
Footnotes Footnote
The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, October 18, 2018.

Owner Signature

Signature Name
/s/ Matthias Jaffe, as Attorney-in-Fact
Signature Date
2018-10-22
Additional Files
FileSequenceDescriptionTypeSize
0000899243-18-027231.txt   Complete submission text file   5270
$LOGC

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.